IDH1 GENE MUTATION
Clinical trials for IDH1 GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new IDH1 GENE MUTATION trials appear
Sign up with your email to follow new studies for IDH1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for young brain tumor patients: drug duo targets hard-to-treat gliomas
Disease control OngoingThis early-stage study tests a new drug (BGB-290) combined with chemotherapy (temozolomide) in adolescents and young adults with IDH-mutant gliomas, a type of brain tumor. The goal is to find the safest dose and check for side effects. About 78 participants with newly diagnosed o…
Matched conditions: IDH1 GENE MUTATION
Phase: PHASE1 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New hope for rare bone cancer: targeted drug AG-120 shows promise
Disease control OngoingThis study tests a drug called AG-120 in people with a rare bone cancer (chondrosarcoma) that has a specific genetic change (IDH1 mutation). The goal is to see if the drug can stop or slow the cancer from growing. The study includes 6 adults with advanced or recurrent disease who…
Matched conditions: IDH1 GENE MUTATION
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:53 UTC